Today: 17 April 2026
IBM Stock Gets Citi Buy Call Despite Worst Start Since 2002 as BofA Cuts Target Ahead of Earnings

IBM Stock Gets Citi Buy Call Despite Worst Start Since 2002 as BofA Cuts Target Ahead of Earnings

New York, April 13, 2026, 11:37 EDT

IBM ticked up Monday, gaining about 0.9% to $232.78 in late morning New York action, after Citi Research began coverage with a Buy and set a $285 target. Bank of America, on the other hand, dialed back its own target to $300 just ahead of IBM’s quarterly numbers. Despite today’s move, the stock remains down almost 22% for the year.

IBM faces a dual test here: Wall Street wants to see if enterprise AI demand translates into consistent software gains, and analysts are also sizing up the risk that next-gen AI might erode revenue from IBM’s legacy platforms. Eyes turn to April 22, when Q1 numbers hit and investors get their first look at how last month’s Confluent deal is shaking out.

Barron’s noted that Citi’s Fatima Boolani initiated coverage on IBM following its roughest yearly kickoff since 2002, highlighting the tech giant’s entrenched role in global IT and what she called “unusual” customer stickiness. Boolani, according to Barron’s, also pointed to IBM’s lighter capital requirements compared to the cloud hyperscalers, and flagged the company’s quantum roadmap—IBM claims it’s on track for a fault-tolerant quantum system by 2029. Barron’s

Wamsi Mohan at BofA opted for a cautious approach, trimming his price target on the stock to $300 from $340 but sticking with a Buy. He expects Confluent to tack on about $50 million in first-quarter revenue after the March 17 close. Still, he warned, a full quarter of acquisition dilution probably drags down second-quarter earnings per share—a key profit metric.

BofA expects IBM to stick with its 2026 outlook, while attention shifts to how Confluent integration plays out, what’s happening with Red Hat, and whether software and consulting growth holds up. The bank flagged 2026 as a quieter year, with IBM working through the acquisition and investors still uneasy about AI potentially replacing jobs done by traditional software providers.

IBM’s latest numbers give it something to talk about. Back in January, Reuters noted the company topped fourth-quarter expectations, pulling in $19.69 billion in revenue and reporting adjusted earnings of $4.52 per share—boosted by AI-driven software sales. Software revenue hit $9.03 billion. The AI business alone climbed to $12.5 billion, but IBM said it won’t be disclosing that particular figure starting with the first quarter.

The Confluent acquisition is a central plank in IBM’s strategy. After the $11 billion deal closed on March 17, software head Rob Thomas argued, “AI decisions need to happen just as fast” as the underlying transactions. Principal analyst Sanjeev Mohan put it differently, noting AI agents require “live operational signals”—not just old data. According to IBM, the platform’s role is to supply real-time data for AI models, agents, and automated workflows running across hybrid cloud environments. IBM Newsroom

The pressure hasn’t eased. Last week, Reuters noted the S&P 500 Software and Services Index has tumbled 25.5% in 2026, with Adobe, Salesforce, and Intuit all dragged down by renewed worries over AI-driven disruption. IBM got hit hard too—back in February, its shares suffered their sharpest single-day plunge since 2000 after Anthropic introduced its Claude Code tool, which it claims can overhaul COBOL—the legacy programming language still crucial to IBM mainframes used in banks and government—for “quarters instead of years.” Reuters

The stakes for April 22 are clear. IBM needs to prove that appetite for AI, data products, and consulting can outpace the drag from legacy segments and that it can take in Confluent without eroding margins. “We’re getting back to being concerned about the prior software-specific concerns stemming from AI,” Interactive Brokers’ Steve Sosnick told Reuters last week. JonesTrading’s Michael O’Rourke added that the pace of AI innovation is “exposing the weakness of the current software that’s out there.” Reuters

Despite the reduced target on Monday, BofA is sticking with $300, and Citi holds at $285—both higher than where IBM currently trades. The company is scheduled to report after the bell on April 22.

Stock Market Today

  • MasterCraft and Leisure Products Stocks Show Mixed Q4 Results Amid Consumer Caution
    April 16, 2026, 10:06 PM EDT. Consumer discretionary leisure products stocks showed mixed outcomes in Q4, with revenues beating estimates by 4.6% but share prices dropping 4.2% on average post-earnings. MasterCraft (NASDAQ:MCFT) reported $71.76 million revenue, up 13.2%, surpassing analyst expectations by 4.1%, yet its stock fell 5% to $21.96. The sector faces structural challenges due to discretionary spending's sensitivity to economic cycles, excess inventory, and cost pressures from inflation and imports. Despite these headwinds, some companies, including Smith & Wesson (NASDAQ:SWBI), which posted 17.1% revenue growth, outperformed forecasts. The mix of earnings beats and cautious outlooks illustrates ongoing demand uncertainties in leisure products amid shifting consumer behavior.

Latest article

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
Salesforce Stock News: Choreo and Sumitomo Mitsui Cuts Resurface, but the Filings Are Months Old
Previous Story

Salesforce Stock News: Choreo and Sumitomo Mitsui Cuts Resurface, but the Filings Are Months Old

Nebius Stock (NBIS) Jumps as BofA Backs AI Trade, but Downgrade Flags Valuation Risk
Next Story

Nebius Stock (NBIS) Jumps as BofA Backs AI Trade, but Downgrade Flags Valuation Risk

Go toTop